Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
LumiThera, Inc. logo — Valeda is FDA Authorized in the US, CE Marked in the EU, and...

LumiThera, Inc.

Valeda is FDA Authorized in the US, CE Marked in the EU, and available in select countries in Latin America.

Founded 2013 United States Poulsbo, United States 34 employees Venture round Total: $27.43M Health Care, Manufacturing +1

General Information

Company Name LumiThera, Inc.
Founded Year 2013
Location United States Poulsbo, United States
Founders / Decision Makers
Team member
Employees 34
Industries Health Care, Manufacturing, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with LumiThera, Inc.. To contact LumiThera, Inc., visit lumithera.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does LumiThera, Inc. compare?

A PDF of LumiThera, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting LumiThera, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About LumiThera, Inc.

LumiThera, Inc. is a United States-based startup focused on developing therapies for degenerative eye diseases using Photobiomodulation. The company's flagship product, the Valeda® Light Delivery System, utilizes multiwavelength photobiomodulation to treat dry age-related macular degeneration (AMD). While CE Marked in the EU and available in select Latin American countries, it is not cleared by the Food & Drug Administration (FDA) in the USA. Additionally, their AdaptDx Pro® dark adaptation functional testing technology allows early detection and monitoring of AMD, and the Diopsys® ERG and VEP systems aid in analyzing visual and neuro-visual disorders. The last recorded investment for LumiThera was a significant $2.43M Venture Round investment on May 21, 2024. As the company continues to advance its innovative light-based solutions in the healthcare and manufacturing industries, it presents an intriguing opportunity for venture capital firms seeking to support groundbreaking technologies addressing critical medical needs.

Business keywords: photobiomodulation, ophthalmology, non-invasive treatments, dry age-related macular degeneration, clinical trials, vision improvement, eye diseases, innovation, CE Mark, European market, non-invasive medical treatments, Valeda Light Delivery System, clinical studies, light emitting diodes

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $2.43M -
21 May 2024
Debt Financing $5.50M 3
Keiretsu Capital Serengeti Asset Management
Keiretsu Capital, Serengeti Asset Management +1
10 Mar 2022
Series C $14.00M 4
Keiretsu Capital Celeste Management WaterStart Capital
Keiretsu Capital, Celeste Management +2
08 Jul 2020
Series B $5.50M 3
Keiretsu Capital
Keiretsu Capital, WaterStone Capital +1
31 Oct 2017
Venture Round Undisclosed 1
Puget Sound Venture Club
Puget Sound Venture Club
01 Dec 2016
Series A Undisclosed 1
Keiretsu Capital
Keiretsu Capital
08 Apr 2016

LumiThera, Inc. Alternatives & Competitors

LumiThera, Inc. vs
Diabeloop
Diabeloop France

Medtech seeking to reduce the mental burden associated with diabetes thanks to interoperable self-le...

Venture round
106 employees
Health Care, Medical Devices
Compare LumiThera, Inc. vs Diabeloop

FAQ About LumiThera, Inc.

Valeda is FDA Authorized in the US, CE Marked in the EU, and available in select countries in Latin America.
LumiThera, Inc. was founded in 2013.
LumiThera, Inc. is headquartered in Poulsbo, United States.
LumiThera, Inc. operates in Health Care, Manufacturing and Medical Devices. Its work centres on photobiomodulation, ophthalmology, non-invasive treatments and dry age-related macular degeneration.
LumiThera, Inc. has approximately 34 employees.
LumiThera, Inc. has completed 6 funding rounds, raising a total of $27.43M. The latest funding stage is Venture round.
Top alternatives and competitors to LumiThera, Inc. include Diabeloop. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
LumiThera, Inc. and Diabeloop are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for LumiThera, Inc., https://bouncewatch.com/company/lumithera-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout